熱門資訊> 正文
Cyclacel Pharmaceuticals申请为股东出售1520万股股票
2024-05-07 05:54
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) on Monday filed a prospectus related to a proposed resale of about 15.2M shares of its common stock by selling stockholders.
- This prospectus is not an offer to sell these securities.
- SEC Filing
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
- Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34
- Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
- Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals
- Historical earnings data for Cyclacel Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
